Concepedia

Anton Megens

AM

Statistics

Publications

24

Citations

1.2K

H-Index

19

Active since

1986

Affiliations

Janssen (Belgium)(Current)

Johnson & Johnson (United States)

Anton Megens is an author at Janssen (Belgium) specializing in pharmacology, medicine, and neuropharmacology.

Publications per year

1986–2014

24

Publications

24

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

Paul A. J. Janssen, C. J. E. Niemegeers, F. Awouters et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 468 citations

Medicine, Pharmacology, Pharmacotherapy +14

Does phenylethylamine act as an endogenous amphetamine in some patients?

Paul A. J. Janssen, Josée E. Leysen, Anton Megens et al. · The International Journal of Neuropsychopharmacology · 1999 · 83 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

Discovery of New Tetracyclic Tetrahydrofuran Derivatives as Potential Broad-Spectrum Psychotropic Agents

Javier Fernández, José Manuel Alonso Segura, José Ignacio Andrés et al. · Journal of Medicinal Chemistry · 2004 · 74 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of a New Series of Centrally Active Tricyclic Isoxazoles Combining Serotonin (5-HT) Reuptake Inhibition with α<sub>2</sub>-Adrenoceptor Blocking Activity

José Ignacio Andrés, Jesús Alcázar, José Manuel Alonso Segura et al. · Journal of Medicinal Chemistry · 2004 · 50 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Discovery of a Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitor for the Potential Treatment of Schizophrenia

José Manuel Bartolomé-Nebreda, Francisca Delgado, Maria Luz Martı́n-Martı́n et al. · Journal of Medicinal Chemistry · 2014 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

1–5 of 24